VONOPRAZAN-AMOXICILLIN DUAL THERAPY VERSUS BISMUTH-BASED QUADRUPLE THERAPY FOR TREATMENT OF HELICOBACTER PYLORI INFECTION: A SYSTEMATIC REVIEW AND META-ANALYSIS

被引：0
|
作者：
Abosheaishaa, Hazem
Elsayed, Hesham
Harfoush, Mohamed K.
Abusuliman, Mohammed
Abdelhalim, Omar
Mohamed, Islam
Sethi, Arshia
El Haddad, Islam M.
Salem, Ahmed
Nassar, Mahmoud
Karna, Rahul
Bilal, Mohammad
机构：
来源：
GASTROENTEROLOGY | 2024年 / 166卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1384
引用
收藏
页码：S439 / S439
页数：1
相关论文
共 50 条
  • [11] High-Dose Dual Therapy Versus Bismuth-Containing Quadruple Therapy for the Treatment of Helicobacter pylori Infection: A Systematic Review with Meta-Analysis
    Yin, Zhikun
    Li, Ji
    Huang, Weifeng
    Lei, Xiaoyi
    Xu, Dong
    Xu, Guihua
    Li, Hua
    Zhang, Jinyan
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2022, 33 (06): : 454 - 462
  • [12] The efficacy and safety of vonoprazan–amoxicillin dual therapy in eradicating Helicobacter pylori: a systematic review and meta-analysis
    Jia-Hui Feng
    Jie Cheng
    Yao-Jia Lao
    Kai Huang
    Juan-Li Mou
    Fan Hu
    Meng-Lu Lin
    Jun Lin
    European Journal of Medical Research, 28
  • [13] BISMUTH QUADRUPLE THERAPY VERSUS CONCOMITANT THERAPY FOR THE FIRST-LINE TREATMENT OF HELICOBACTER PYLORI INFECTION: SYSTEMATIC REVIEW AND META-ANALYSIS
    Dajti, E.
    Cominardi, A.
    Frazzoni, L.
    Fuccio, L.
    Eusebi, L. H.
    Vestito, A.
    Lisotti, A.
    Galloro, G.
    Romano, M.
    Bazzoli, F.
    Zagari, R. M.
    DIGESTIVE AND LIVER DISEASE, 2023, 55 : S173 - S174
  • [14] Efficacy and Safety of Vonoprazan and Amoxicillin Dual Therapy for Helicobacter pylori Eradication: A Systematic Review and Meta-Analysis
    Zhang, Wen-Lin
    Lin, Bo-Shen
    Li, Yue-Yue
    Ding, Yu-Ming
    Han, Zhong-Xue
    Ji, Rui
    DIGESTION, 2023, 104 (04) : 249 - 261
  • [15] Analysis of oral microbiota alterations induced by Helicobacter pylori infection and vonoprazan-amoxicillin dual therapy for Helicobacter pylori eradication
    Hu, Yi
    Xu, Xin
    Ouyang, Yao-Bin
    He, Cong
    Li, Nian-Shuang
    Xie, Chuan
    Peng, Chao
    Zhu, Zhen-Hua
    Xie, Yong
    Shu, Xu
    Lu, Nong-Hua
    Zhu, Yin
    HELICOBACTER, 2022, 27 (05)
  • [16] Superiority of Bismuth-Based Quadruple Therapy vs. Standard Triple Therapy for Empiric Primary Treatment of Helicobacter pylori Infection: Systematic Review and Meta-Analysis of Efficacy and Tolerability
    Venerito, Marino
    Krieger, Tina
    Ecker, Thomas
    Malfertheiner, Peter
    GASTROENTEROLOGY, 2012, 142 (05) : S487 - S487
  • [17] Vonoprazan-amoxicillin combination therapy for Helicobacter pylori eradication: an umbrella review of meta-analyses
    Syed, Saif
    Zehra, Fatima Tu
    Zaman, Maham
    Karmani, Vikash Kumar
    Saleem, Ayesha
    Khalid, Momina
    Asim, Syeda Nimrah
    Izhar, Sara
    Suhagiya, Gaurang Hasmukhbhai
    EGYPTIAN JOURNAL OF INTERNAL MEDICINE, 2024, 36 (01):
  • [18] Meta-Analysis of Bismuth Quadruple Therapy versus Clarithromycin Triple Therapy for Empiric Primary Treatment of Helicobacter pylori Infection
    Venerito, Marino
    Krieger, Tina
    Ecker, Thomas
    Leandro, Gioacchino
    Malfertheiner, Peter
    DIGESTION, 2013, 88 (01) : 33 - 45
  • [19] PPI-amoxicillin dual therapy for Helicobacter pylori infection: An update based on a systematic review and meta-analysis
    Gao, Cai-Ping
    Zhang, Di
    Zhang, Ting
    Wang, Jin-Xia
    Han, Sheng-Xi
    Graham, David Y.
    Lu, Hong
    HELICOBACTER, 2020, 25 (04)
  • [20] Comparative efficacy and safety of high-dose dual therapy, bismuth-based quadruple therapy and non-bismuth quadruple therapies for Helicobacter pylori infection: a network meta-analysis
    Xu, Huimei
    Wang, Wancong
    Ma, Xueni
    Feng, Rukun
    Su, Yujing
    Cheng, Long
    Yang, Yifan
    Zhang, Dekui
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (06) : 775 - 786
12345